Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | MAL |
| Gene Name: | MAL |
| Protein Full Name: | Myelin and lymphocyte protein |
| Alias: | T-lymphocyte maturation-associated protein |
| Mass (Da): | 16714 |
| Number AA: | 153 |
| UniProt ID: | P21145 |
| Locus ID: | 4118 |
| COSMIC ID: | MAL |
| Gene location on chromosome: | 2q11.1 |
| Cancer protein type: | BOTH |
| Effect of cancer mutation on protein: | UNCLEAR |
| Effect of active protein on cancer: | MIXED |
| Number of cancer specimens: | 19625 |
| Percent of cancer specimens with mutations: | 0.19 |
| Gene undergoes hypermethylation: | MAL |
| Normal role description: | Could be an important component in vesicular trafficking cycling between the Golgi complex and the apical plasma membrane. Could be involved in myelin biogenesis and/or myelin function. |